Subscribe Sign In Register

Premium

Pfizer-Wyeth: It’s a chemical reaction

Wide spreads lure merger arb players into Pfizer-Wyeth bet.

August 24, 2009
insidethetrade-100x102.gif

By Josh Friedlander

chemical-reaction.gif

For merger arbitrageurs, deals don’t get any better than pharmaceutical giant Pfizer’s proposed acquisition of competitor Wyeth.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Wyeth Pfizer Merger Arbitrage
Related
Bear market in the US stock market
Hedge Funds
Macro Fund Haidar Jupiter Rings Up More Losses
Steve Taub
November 7, 2024
USA, Massachusetts, Boston, Financial District, Composite image of illuminated financial district at dusk
Hedge Funds
Dan Loeb’s Hedge Fund Is Within Striking Distance of Its Best Results Since 2021
Steve Taub
November 6, 2024
Active_Thematics_700x550.jpg
Sponsored
Thematic Equity : The Active Element of a Global Portfolio